Background: A palpable breast lump is always a cause of concern to the patient. Hence,rnaccurate pathological diagnosis is crucial for further management and to evaluate the outcome. rnClinical examination, imaging and FNAB are implemented in the assessment of breast lesions inrnthe Triple Test. In this regard the role of FNAB is vital in the diagnoses of breast lesionsrnparticularly in identifying malignant lesions. rnObjectives: The aim of this study was to determine cytopathologic patterns of breast lesions inrnTASH and to correlate Fine Needle Aspiration Biopsy results with the corresponding rnhistopathologic results as to determine the validity of FNAB. rnMethods: A retrospective descriptive cross-sectional study of 1327 patients who underwentrnFNAB of whom 145 had histopathology results over six years and eight months between January rn2015 and August 2021 in TASH. Descriptive statistics of the cytology reports as well asrndiagnostic performance analysis of malignant and benign FNAB categories made using SPSSrnversion 23. rnResults: A total number of 1327 patients were included out of which 1214 (91.5%) werernfemales and 113 (8.5%) were males. According to the IAC Yokohama system the malignant and rnbenign categories of FNAB account 44% each of the total cases and the rest contributed by thernsuspicious, atypical and insufficient categories. Most of the Malignancies present in the 4rnthrn andrn5rnthrn decades of life whereas benign cases happened a decade earlier. 145 of the cases were rnfollowed by histopathology. FNAB of benign and malignant lesions showed 96.0% accuracy, rn96.3% sensitivity and 97.7% specificity. rnConclusion: The burden of malignancy in this setup (TASH) is high yet, FNAB remains to berna reliable and acceptable method for the diagnosis of breast lesions.